| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/06/1993 | US5225238 Method for coating active principles with a ph-sensitive polymer |
| 07/06/1993 | US5225205 Pharmaceutical composition in the form of microparticles |
| 07/06/1993 | US5225193 Bordetella toxin peptides and vaccines |
| 07/06/1993 | US5225182 For specific organ delivery |
| 07/06/1993 | US5225181 Labeling with radioactive iodine or metal |
| 07/06/1993 | CA1319899C Monoclonal antibodies to fc receptors for immunoglobulin g on human mononuclear phagocytes |
| 07/01/1993 | DE4244418A1 Cosmetic and pharmaceutical compsn. contg. specific tri:peptide(s) - is prepd. by controlled hydrolysis of collagen, etc., for stimulating cell respiration or collagen synthesis, etc. |
| 07/01/1993 | CA2086362A1 Sex specific promoter |
| 06/30/1993 | EP0549281A1 Dentinal desensitizing compositions |
| 06/30/1993 | EP0549002A1 Method for the preparation of an antiseptic composition containing clindamycin-hydrochloride and polymyxin |
| 06/30/1993 | EP0548867A2 Soluble stem cell factor (SFC)-receptor |
| 06/30/1993 | EP0548825A1 Bradykinin-antagonists for the treatment of acute pancreatitis |
| 06/30/1993 | EP0548794A2 Polyaspartamide derivative as adsorbent for bile acids, polyaspartamide loaded with bile acids and preparation and use as a drug |
| 06/30/1993 | EP0548441A1 Endothelin antagonists |
| 06/30/1993 | EP0548376A1 Antitumor drug |
| 06/30/1993 | EP0548276A1 Method for increasing red blood cell production by treatment with activin or activin-related peptides |
| 06/30/1993 | EP0548248A1 Methods for producing acyloxyacyl hydrolase |
| 06/30/1993 | EP0548234A1 Cloning of chicken anaemia dna |
| 06/30/1993 | EP0548214A1 EXPRESSION OF MACROPHAGE INDUCIBLE PROTEINS (MIPs) IN YEAST CELLS |
| 06/30/1993 | EP0548210A1 Liposomes |
| 06/30/1993 | EP0548200A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 06/30/1993 | EP0548190A1 Novel antibodies for treatment and prevention of infection in animals and man |
| 06/30/1993 | EP0548123A1 Anti-inflammatory factor, method of isolation, and use |
| 06/30/1993 | EP0548095A1 Pharmaceutical compositions containing superoxide dismutase from bacillus stearothermophilus and bacillus caldotenax |
| 06/30/1993 | EP0548083A1 Nerve-regenerating agent |
| 06/30/1993 | EP0528875A4 Enzymatic disinsertion of vitreous body |
| 06/30/1993 | EP0522073A4 Improved major histocompatibility complex (mhc) molecules |
| 06/30/1993 | EP0441939A4 Wound healing |
| 06/30/1993 | CN1073684A Polypeptide analogues having growth hormone releasing activity |
| 06/30/1993 | CN1073683A Organic salts of N,N'-diacetyl cystine |
| 06/30/1993 | CN1073603A Anetic kinin antagon for curing acute pancreatitis |
| 06/29/1993 | WO1993008282A1 New thrombin-inhibiting protein isolated from ticks |
| 06/29/1993 | US5223615 Dipeptide derivatives |
| 06/29/1993 | US5223605 Interleukin-4 binding protein-γ |
| 06/29/1993 | US5223529 N-phenylamides and medicinal products containing them |
| 06/29/1993 | US5223488 Oxidized-type glutathione alkyl ester |
| 06/29/1993 | US5223487 Tri-, tetra-, penta- and hexapeptatides of Asp, Gly, Lys, Ser, Ala and salts |
| 06/29/1993 | US5223486 Modified oligopeptide containing a diazomethyl ketone group or methylsulfonium group |
| 06/29/1993 | US5223485 Anaphylatoxin-receptor ligands |
| 06/29/1993 | US5223484 Dodecapeptide containing cysteine, histidine, arginine, lysine, glycine, tyrosine, alanine, aspartic acid, leucine |
| 06/29/1993 | US5223483 Cysteine-modified acidic fibroblast growth factor |
| 06/29/1993 | US5223482 Polypeptide |
| 06/29/1993 | US5223481 Biologically active lipoprotein and its use |
| 06/29/1993 | US5223427 Synthetic polypeptide |
| 06/29/1993 | US5223426 Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor |
| 06/29/1993 | US5223425 DNA sequence which codes serine protease for diagnosis and/or treatment of obesity or metabolic defects |
| 06/29/1993 | US5223422 T-pa mutant gk1l |
| 06/29/1993 | US5223420 Elastin-based product, a procedure for its preparation and its biological applications; in particular as biomaterials and artificial supports |
| 06/29/1993 | US5223410 Method for production of antibodies utilizing an antigen-free animal |
| 06/29/1993 | US5223409 Directed evolution of novel binding proteins |
| 06/29/1993 | US5223408 Method for making variant secreted proteins with altered properties |
| 06/29/1993 | US5223406 Process of using catabolic enzymes for induction of tumor necrosis factor (tnf) |
| 06/29/1993 | US5223394 Recombinant dna molecule comprising lymphocyte function-associated antigen 3 phosphatidylinositol linkage signal sequence |
| 06/29/1993 | US5223256 Thrombolytically active non-glycosylated protein |
| 06/29/1993 | CA2121134A1 Novel thrombin-inhibitory protein from ticks |
| 06/29/1993 | CA1319611C Purified hemoglobin solutions and method for making same |
| 06/29/1993 | CA1319610C Method for inducing endogenous production of tissue plasminogen activator (tpa) |
| 06/29/1993 | CA1319609C Carcass quality |
| 06/29/1993 | CA1319608C Electrolytic transdermal delivery of proteins |
| 06/28/1993 | CA2086079A1 Peptide, production and use thereof |
| 06/25/1993 | WO1993012806A1 A method for the treatment of tumours and sarcomas |
| 06/25/1993 | CA2086142A1 Prolyl endopeptidase inhibitor |
| 06/24/1993 | WO1994012205A1 Dynorphin a suppression of natural killer cell activity |
| 06/24/1993 | WO1993012251A1 Senescent cell derived inhibitors of dna synthesis |
| 06/24/1993 | WO1993012248A1 Ligands and binding partner for treatment and diagnosis of inflammatory conditions |
| 06/24/1993 | WO1993012238A1 t-PA SUBSTITUTION VARIANTS WITH IMPROVED FIBRIN-SPECIFICITY |
| 06/24/1993 | WO1993012234A1 Antiviral reagents based on rna-binding proteins |
| 06/24/1993 | WO1993012232A1 Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof |
| 06/24/1993 | WO1993012231A1 Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
| 06/24/1993 | WO1993012230A1 Triple-helix formation at (punpyn).(punpyn) tracts |
| 06/24/1993 | WO1993012228A1 Method for generating structural and functional diversity in a peptide sequence |
| 06/24/1993 | WO1993012227A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 06/24/1993 | WO1993012226A1 Novel plasmodium protease |
| 06/24/1993 | WO1993012225A1 Novel tissue plasminogen activator variants |
| 06/24/1993 | WO1993012220A1 RECOMBINANT AND CHIMERIC ANTIBODIES TO c-erbB-2 |
| 06/24/1993 | WO1993012146A1 Trophoblast interferons and their use |
| 06/24/1993 | WO1993012145A1 Pva or peg conjugates of peptides for epitope-specific immunosuppression |
| 06/24/1993 | WO1993012143A1 Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 06/24/1993 | WO1993012142A1 Cytokines with an unpaired cysteine residue and conjugates thereof |
| 06/24/1993 | WO1993012140A1 Peptide with cell adhesion activity and polymeric modification thereof |
| 06/24/1993 | WO1993012138A1 Compounds and compositions for treating hiv infections |
| 06/24/1993 | WO1993012136A1 Detection and treatment of acute leukemias resulting from chromosome abnormalities in the all-1 region |
| 06/24/1993 | WO1993012129A1 Peptide nucleic acids and their effect on genetic material |
| 06/24/1993 | WO1993012077A1 Cyclopropyl n-hydroxyurea and n-hydroxyacetamides which inhibit lipoxygenase |
| 06/24/1993 | WO1993012068A1 S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof |
| 06/24/1993 | WO1993011844A1 A method for coated particles in a spray-drying plant |
| 06/24/1993 | WO1993011799A1 Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation |
| 06/24/1993 | WO1993011797A1 Drug containing an atriopeptidase inhibitor and at least one calcic antagonist |
| 06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 06/24/1993 | WO1993011789A1 Modified position (7) bradykinin antagonist peptides |
| 06/24/1993 | WO1993011788A1 Gonadotropin containing pharmaceutical compositions with sucrose stabilizer |
| 06/24/1993 | WO1993011787A1 Blood pressure regulator |
| 06/24/1993 | WO1993011786A1 Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
| 06/24/1993 | WO1993011785A1 Stabilized parathyroid hormone composition |
| 06/24/1993 | WO1993011784A1 Methods for inhibition or stimulation of the inflammatory response |
| 06/24/1993 | WO1993011783A1 Composition and treatment with biologically active peptides and chelating agents |
| 06/24/1993 | WO1993011782A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
| 06/24/1993 | WO1993011781A1 Synthetic compounds and compositions with enhanced cell binding |
| 06/24/1993 | WO1993011778A1 Bifunctional antithrombotic molecules and antithrombotic polypeptides |
| 06/24/1993 | WO1993011769A1 Carcinostatic |